Senores Pharmaceuticals Limited (NSE:SENORES)
India flag India · Delayed Price · Currency is INR
744.95
+25.35 (3.52%)
At close: Sep 8, 2025

Senores Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22
33,11926,278---
Enterprise Value
32,67328,923---
Last Close Price
719.15570.60---
PE Ratio
41.6644.87---
PS Ratio
7.276.60---
PB Ratio
4.083.24---
P/TBV Ratio
5.864.65---
EV/Sales Ratio
7.177.26---
EV/EBITDA Ratio
31.8132.78---
EV/EBIT Ratio
39.2539.69---
Debt / Equity Ratio
0.390.391.111.380.40
Debt / EBITDA Ratio
3.063.516.285.5610.62
Asset Turnover
-0.430.570.37-
Inventory Turnover
-3.995.384.19-
Quick Ratio
-2.600.770.742.31
Current Ratio
-3.001.010.992.74
Return on Equity (ROE)
-11.18%23.59%20.55%-
Return on Assets (ROA)
-4.93%5.24%7.16%-
Return on Capital (ROIC)
-5.64%6.61%8.54%-
Return on Capital Employed (ROCE)
-7.40%8.40%13.80%2.50%
Earnings Yield
2.04%2.23%---
FCF Yield
--7.74%---
Buyback Yield / Dilution
-208.55%-41.13%-103.16%-131.33%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.